Track CLDI and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CLDI - Calidi Biotherapeutics Inc. (CLDI) has a earnings per share of -$2.21, up 71.7% over the past year.
Latest EPS (Actual)
-$2.21
Beat Rate
25.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Nov 2025 | -$1.68 | -$2.21 | Miss | -31.55% |
| Aug 2025 | -$1.32 | -$1.99 | Miss | -50.76% |
| May 2025 | -$1.80 | -$2.25 | Miss | -25.00% |
| Mar 2025 | -$0.09 | -$0.27 | Miss | -200.00% |
| Nov 2024 | -$10.26 | -$7.80 | Beat | +23.98% |
| Aug 2024 | -$17.40 | -$16.80 | Meet | +3.45% |
| May 2024 | -$32.40 | -$23.71 | Beat | +26.82% |
| Mar 2024 | -$0.20 | -$0.48 | Miss | -140.00% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.